Literature DB >> 14722299

A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Christina Jenkins1, Allison Abendroth, Barry Slobedman.   

Abstract

Human cytomegalovirus (CMV) establishes latent infections in hematopoietic cells such as granulocyte-macrophage progenitors (GM-Ps). During latency the virus is sequestered in a nonreplicating state, although limited transcriptional activity has been previously reported. In this study we sought to further examine viral gene expression during the latent phase of infection. Using an experimental model of latency, primary human GM-Ps were latently infected with CMV strain Toledo and extracted RNA subjected to reverse transcription-PCR by using CMV gene-specific primers. Using this approach, we detected transcription from the UL111.5A region of the viral genome. This transcription was also detected in GM-Ps latently infected with AD169 and Towne strains, indicating that expression was CMV strain independent. Significantly, we detected UL111.5A-region transcripts in mononuclear cells from healthy bone marrow and mobilized peripheral blood allograft donors, demonstrating expression during natural latent infection. Mapping experiments with RNA extracted from latently infected GM-Ps revealed the expression of a novel UL111.5A region transcript with a splicing pattern that differed from that reported during productive infection of permissive cells. This UL111.5A region transcript expressed during latent infection is predicted to encode a 139-amino-acid protein with homology to the potent immunosuppressor interleukin-10 (IL-10) and to the viral IL-10 homolog that is expressed during productive CMV infection. Expression of a latency-associated cmvIL-10 may confer upon the virus an ability to avoid immune recognition and clearance during the latent phase of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722299      PMCID: PMC321375          DOI: 10.1128/jvi.78.3.1440-1447.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors.

Authors:  Barry Slobedman; Edward S Mocarski; Ann M Arvin; Elizabeth D Mellins; Allison Abendroth
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

2.  Immunisation trials with live attenuated cytomegalovirus TOWNE 125.

Authors:  M Just; A Buergin-Wolff; G Emoedi; R Hernandez
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 3.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.

Authors:  P Stanier; D L Taylor; A D Kitchen; N Wales; Y Tryhorn; A S Tyms
Journal:  BMJ       Date:  1989-10-07

5.  Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.

Authors:  G V Quinnan; M Delery; A H Rook; W R Frederick; J S Epstein; J F Manischewitz; L Jackson; K M Ramsey; K Mittal; S A Plotkin
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

6.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

7.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Authors:  D H Hsu; R de Waal Malefyt; D F Fiorentino; M N Dang; P Vieira; J de Vries; H Spits; T R Mosmann; K W Moore
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

8.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

9.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

10.  Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.

Authors:  Mathieu S Chevalier; Gwynn M Daniels; David C Johnson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  98 in total

1.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

2.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

3.  Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Authors:  Ryan T Saffert; Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

Review 4.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

Review 5.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

6.  The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.

Authors:  Christina Montag; Jutta Annabella Wagner; Iris Gruska; Barbara Vetter; Lüder Wiebusch; Christian Hagemeier
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

Authors:  Alex Petrucelli; Michael Rak; Lora Grainger; Felicia Goodrum
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.

Authors:  Luca Bruno; Mirko Cortese; Giuseppina Monda; Michela Gentile; Stefano Calò; Francesca Schiavetti; Luisanna Zedda; Elena Cattaneo; Diego Piccioli; Mary Schaefer; Eugenio Notomista; Domenico Maione; Andrea Carfì; Marcello Merola; Yasushi Uematsu
Journal:  Immunol Cell Biol       Date:  2016-05-19       Impact factor: 5.126

9.  The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.

Authors:  Andreas Busche; Anja Marquardt; Andre Bleich; Peter Ghazal; Ana Angulo; Martin Messerle
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Authors:  Martin Zydek; Christian Hagemeier; Lüder Wiebusch
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.